Table 1
Inclusion and exclusion criteria.
| | Inclusion criteria | | (1) Patients who meet the Rome III diagnosis standard of functional dyspepsia. | | (2) Patients who have cold and heat in complexity syndrome. | | (3) Patients aged 18 to 65 without gender limitation. | | (4) Singed the informed consent. | | Exclusion criteria | | (1) Patients who combined with GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa, or suspicious | | malignant lesion. | | (2) Patients who have overlap syndrome combined with gastroesophageal reflux disease or irritable bowel syndrome. | | (3) Patients whose syndrome is difficult to differentiate. | | (4) Patients who have connective tissue diseases, diabetes or other endocrine disease, climacteric syndrome, or severe diseases in heart, | | liver, lung, kidney, or blood. | | (5) Pregnant or lactating women. Disabled people. | | (6) Patients with history of alcoholic or drug abuse. | | (7) Patients who have allergic constitution or known to be allergic to the drug used in this trial. | | (8) Patients who are involved in other trials. | | (9) Patients with poor compliance or other reasons that the researcher considered not to be appropriate to participate in this trial. | | (10) Patients with severe depression and have suicidal tendency. |
|
|
